Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows. The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide. Read More
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face increasing pressure to generate high-quality data earlier and make confident decisions faster. Thermo Fisher’s latest innovations address these needs by combining high-performance instrumentation with AI-enabled software for scalable multiomics and biopharmaceutical solutions to expedite both discovery and development. Together, these capabilities help scientists identify and validate disease mechanisms more efficiently, advancing targeted treatments.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company’s industry leadership and the essential role of its best-in-class products and services to customers around the world.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t...
Thermo Fisher’s first quarter results received a negative market reaction, despite topping Wall Street’s revenue expectations and delivering non-GAAP earning...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.
Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 6.2% year on year to $11...
What Happened? Shares of life sciences company Thermo Fisher (NYSE:TMO) fell 10.5% in the afternoon session after the company reported first-quarter results ...
Life sciences company Thermo Fisher (NYSE:TMO) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 6.2% year on year to $11.01 billion. Its n...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026.
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings this Thursday before the bell. Here’s what to look for. Thermo Fisher beat analysts...
